Filing Details

Accession Number:
0001144204-18-039048
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-19 21:01:02
Reporting Period:
2018-07-17
Accepted Time:
2018-07-19 21:01:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1069899 Phibro Animal Health Corp PAHC Pharmaceutical Preparations (2834) 131840497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1241560 Jack Bendheim 300 Frank W. Burr Blvd., Ste 21
Teaneck NJ 07666
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2018-07-17 17,470 $0.00 47,470 No 4 C Indirect See
Class A Common Stock Disposition 2018-07-17 9,470 $48.20 38,000 No 4 S Indirect See
Class A Common Stock Disposition 2018-07-18 4,000 $47.95 34,000 No 4 S Indirect See
Class A Common Stock Disposition 2018-07-19 4,000 $47.22 30,000 No 4 S Indirect See
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See
No 4 S Indirect See
No 4 S Indirect See
No 4 S Indirect See
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class B Common Stock Disposition 2018-07-17 17,470 $0.00 17,470 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,318,034 No 4 C Direct
Footnotes
  1. Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
  3. The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFICo., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficialownership of these securities except to the extent of his pecuniary interest therein.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.95 to $48.50, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.75 to $48.40, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.10 to $47.40, inclusive.